Literature DB >> 10331978

rhomboid and Star interact synergistically to promote EGFR/MAPK signaling during Drosophila wing vein development.

A Guichard1, B Biehs, M A Sturtevant, L Wickline, J Chacko, K Howard, E Bier.   

Abstract

Genes of the ventrolateral group in Drosophila are dedicated to developmental regulation of Egfr signaling in multiple processes including wing vein development. Among these genes, Egfr encodes the Drosophila EGF-Receptor, spitz (spi) and vein (vn) encode EGF-related ligands, and rhomboid (rho) and Star (S) encode membrane proteins. In this study, we show that rho-mediated hyperactivation of the EGFR/MAPK pathway is required for vein formation throughout late larval and early pupal development. Consistent with this observation, rho activity is necessary and sufficient to activate MAPK in vein primordium during late larval and early pupal stages. Epistasis studies using a dominant negative version of Egfr and a ligand-independent activated form of Egfr suggest that rho acts upstream of the receptor. We show that rho and S function in a common aspect of vein development since loss-of-function clones of rho or S result in nearly identical non-autonomous loss-of-vein phenotypes. Furthermore, mis-expression of rho and S in wild-type and mutant backgrounds reveals that these genes function in a synergistic and co-dependent manner. In contrast, spi does not play an essential role in the wing. These data indicate that rho and S act in concert, but independently of spi, to promote vein development through the EGFR/MAPK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331978     DOI: 10.1242/dev.126.12.2663

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  58 in total

1.  Quantitative trait loci affecting components of wing shape in Drosophila melanogaster.

Authors:  E Zimmerman; A Palsson; G Gibson
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Expression in mammalian cell cultures reveals interdependent, but distinct, functions for Star and Rhomboid proteins in the processing of the Drosophila transforming-growth-factor-alpha homologue Spitz.

Authors:  John C Pascall; Jane E Luck; Kenneth D Brown
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

3.  A fly's eye view of EGF receptor signalling.

Authors:  Matthew Freeman
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Rhomboid and Star facilitate presentation and processing of the Drosophila TGF-alpha homolog Spitz.

Authors:  A G Bang; C Kintner
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

5.  Long-range signal transmission in autocrine relays.

Authors:  Michal Pribyl; Cyrill B Muratov; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

6.  Drosophila-based in vivo assay for the validation of inhibitors of the epidermal growth factor receptor/Ras pathway.

Authors:  Anuradha Aritakula; Annadurai Ramasamy
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

7.  Keren, a new ligand of the Drosophila epidermal growth factor receptor, undergoes two modes of cleavage.

Authors:  Aderet Reich; Ben-Zion Shilo
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

8.  Genetic interaction between integrins and moleskin, a gene encoding a Drosophila homolog of importin-7.

Authors:  Scott E Baker; James A Lorenzen; Steven W Miller; Thomas A Bunch; Alison L Jannuzi; Mark H Ginsberg; Lizabeth A Perkins; Danny L Brower
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

9.  Fasciclin 2, the Drosophila orthologue of neural cell-adhesion molecule, inhibits EGF receptor signalling.

Authors:  Yanlan Mao; Matthew Freeman
Journal:  Development       Date:  2009-02       Impact factor: 6.868

10.  A conserved mechanism for extracellular signaling in eukaryotes and prokaryotes.

Authors:  Marco Gallio; Gwen Sturgill; Philip Rather; Per Kylsten
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.